RT Journal Article
SR Electronic
T1 The distress of Iranian adults during the Covid-19 pandemic – More distressed than the Chinese and with different predictors
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.03.20052571
DO 10.1101/2020.04.03.20052571
A1 Asghar Afshar Jahanshahi
A1 Maryam Mokhtari Dinani
A1 Abbas Nazarian Madavani
A1 Jizhen Li
A1 Stephen X. Zhang
YR 2020
UL http://medrxiv.org/content/early/2020/04/21/2020.04.03.20052571.abstract
AB Early papers on the mental health of the public during the Covid-19 pandemic surveyed participants from China. Outside of China, Iran has emerged as one of the most affected countries with a high death count and rate. The paper presents the first empirical evidence from Iranian adults during the Covid-19 pandemic on their level of distress and its predictors. On March 25–28, 2020, a dire time for Covid-19 in Iran, we surveyed 1058 adults from all 30 provinces in Iran using the Covid-19 Peritraumatic Distress Index (CPDI). The distress level of Iranian adults (mean: 34.54; s.d.: 14.92) was significantly higher (mean difference: 10.9; t=22.7; p<0.0001; 95% CI: 10.0 to 11.8) than that of Chinese adults (mean: 23.65; s.d.: 5.45) as reported in a prior study with the same measure of Covid-19 Peritraumatic Distress Index (CPDI). We also found the predictors of distress in Iran vary from those in China. Our findings that the predictors of distress in Iran vary from those in China suggest the need to study the predictors of mental health in individual countries during the Covid-19 pandemic to effectively identify and screen for those more susceptible to mental health issues.Funding NoneCompeting Interest StatementThe authors have declared no competing interest.Clinical Trialnot applicableFunding StatementThis research was supported (in part) by Tsinghua University-INDITEX Sustainable Development Fund (Project No. TISD201904)Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yesavailable upon request